Unknown

Dataset Information

0

Differential changes in bone strength of two inbred mouse strains following administration of a sclerostin-neutralizing antibody during growth.


ABSTRACT: Administration of sclerostin-neutralizing antibody (Scl-Ab) treatment has been shown to elicit an anabolic bone response in growing and adult mice. Prior work characterized the response of individual mouse strains but did not establish whether the impact of Scl-Ab on whole bone strength would vary across different inbred mouse strains. Herein, we tested the hypothesis that two inbred mouse strains (A/J and C57BL/6J (B6)) will show different whole bone strength outcomes following sclerostin-neutralizing antibody (Scl-Ab) treatment during growth (4.5-8.5 weeks of age). Treated B6 femurs showed a significantly greater stiffness (S) (68.8% vs. 46.0%) and maximum load (ML) (84.7% vs. 44.8%) compared to A/J. Although treated A/J and B6 femurs showed greater cortical area (Ct.Ar) similarly relative to their controls (37.7% in A/J and 41.1% in B6), the location of new bone deposition responsible for the greater mass differed between strains and may explain the greater whole bone strength observed in treated B6 mice. A/J femurs showed periosteal expansion and endocortical infilling, while B6 femurs showed periosteal expansion. Post-yield displacement (PYD) was smaller in treated A/J femurs (-61.2%, p < 0.001) resulting in greater brittleness compared to controls; an effect not present in B6 mice. Inter-strain differences in S, ML, and PYD led to divergent changes in work-to-fracture (Work). Work was 27.2% (p = 0.366) lower in treated A/J mice and 66.2% (p < 0.001) greater in treated B6 mice relative to controls. Our data confirmed the anabolic response to Scl-Ab shown by others, and provided evidence suggesting the mechanical benefits of Scl-Ab administration may be modulated by genetic background, with intrinsic growth patterns of these mice guiding the location of new bone deposition. Whether these differential outcomes will persist in adult and elderly mice remains to be determined.

SUBMITTER: Mathis NJ 

PROVIDER: S-EPMC6448823 | biostudies-literature | 2019

REPOSITORIES: biostudies-literature

altmetric image

Publications

Differential changes in bone strength of two inbred mouse strains following administration of a sclerostin-neutralizing antibody during growth.

Mathis Noah J NJ   Adaniya Emily N EN   Smith Lauren M LM   Robling Alexander G AG   Jepsen Karl J KJ   Schlecht Stephen H SH  

PloS one 20190404 4


Administration of sclerostin-neutralizing antibody (Scl-Ab) treatment has been shown to elicit an anabolic bone response in growing and adult mice. Prior work characterized the response of individual mouse strains but did not establish whether the impact of Scl-Ab on whole bone strength would vary across different inbred mouse strains. Herein, we tested the hypothesis that two inbred mouse strains (A/J and C57BL/6J (B6)) will show different whole bone strength outcomes following sclerostin-neutr  ...[more]

Similar Datasets

2019-07-03 | E-MTAB-8113 | biostudies-arrayexpress
| S-EPMC5413385 | biostudies-literature
| S-EPMC4958115 | biostudies-literature
| S-EPMC8080259 | biostudies-literature
| S-EPMC4616053 | biostudies-other
| PRJEB33292 | ENA
| S-EPMC7770084 | biostudies-literature
| S-EPMC3748979 | biostudies-literature
| S-EPMC6020117 | biostudies-literature
| S-EPMC6909913 | biostudies-literature